CiteFacts · FDA Drug Shortages · FDA source
Triamcinolone Hexacetonide Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Medexus | Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01) | Unavailable | 05/27/2026 |
Source facts
Grouped generic ingredient: Triamcinolone Hexacetonide Injection · 1 package records · Latest FDA row update: 05/27/2026
Therapeutic categories: Rheumatology
Dosage forms: Injection
Routes: INTRA-ARTICULAR
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.